Turn Biotechnologies
Latest round
- Seed
Last raised
- Aug 2019
Total raised
- Undisclosed
Investors
- 2
About Turn Biotechnologies
Founded in 2018 in San Francisco, US, Turn Biotechnologies specializes in epigenetic therapies for age-related cellular dysfunction.13 mn.63 mn.Turn Biotechnologies specializes in developing epigenetic reprogramming therapies designed to combat age-related diseases and restore cellular function. Their flagship product, the Epigenetic Reprogramming of Age (ERA™), employs proprietary mRNA cocktails to enhance cell vitality and target specific tissues.Turn Biotechnologies generates revenue through partnerships and collaborations with research institutions and healthcare organizations, providing access to its ERA™ therapies. Revenue streams include licensing agreements for its proprietary technology and collaborative research and development efforts.13 mn on August 22, 2023, Turn Biotechnologies plans to leverage these funds to advance the development of new epigenetic therapies and expand into major markets in Europe and Asia by 2025. The company aims to enhance its product offerings and broaden its reach in the healthcare sector, targeting additional research collaborations to support their cutting-edge technologies.
Who invested in Turn Biotechnologies
2 investors across 2 rounds
See all investors in Turn Biotechnologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Turn Biotechnologies
Who invested in Turn Biotechnologies?
Turn Biotechnologies has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Turn Biotechnologies raised?
Turn Biotechnologies has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Turn Biotechnologies last raise money?
Turn Biotechnologies's most recent round on record is a Seed, in Aug 2019.
What does Turn Biotechnologies do?
Founded in 2018 in San Francisco, US, Turn Biotechnologies specializes in epigenetic therapies for age-related cellular dysfunction.
Where is Turn Biotechnologies headquartered?
Turn Biotechnologies is headquartered in San Francisco, US.
Which VCs invest in companies like Turn Biotechnologies?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Turn Biotechnologies's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Turn Biotechnologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.